Clinical trial NCT05332886: Metaverse-Based Healthy Life Program for Youth
Official title: The Effect of Metaverse-Based Healthy Life Program on Risk Reduction of Non-Communicable Diseases in Youth
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Health Risk Behaviors
Healthy Lifestyle
Non Communicable Diseases
Health-Related Behavior
Healthy Eating Index
Healthy Nutrition
Physical Inactivity
Stress, Emotional
Lead sponsor: Akdeniz University
Sponsor class: OTHER
Collaborators: name: Horizon
First posted: 2022-04-18
Enrollment: 600
Sex: ALL
Minimum age (years): 15
Maximum age (years): 24
Standard ages: CHILD
ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: Parallel Desing Active Comparative Group Randomized Controlled Trial
Primary purpose: PREVENTION

Brief summary: This study was planned within the scope of the call titled "Non-communicable diseases risk reduction in adolescence and youth (Global Alliance for Chronic Diseases - GACD)" with identity number HORIZON-HLTH-2022-DISEASE-07-03. The purpose of this project; is to determine the effect of the Metaverse-Based Healthy Life Program to be developed in the project to support youths in decreasing future risks of developing non-communicable diseases (NCDs) and in gaining healthy lifestyle behaviors (HLBs).

Detailed description: The project consists of three phases. Phase 1 Testing the content, quality, reliability, and usability of the "Metaverse-Based Healthy Life Program for Youth" to be developed within the scope of the project Phase 2 Identifying youth at high risk of chronic non-communicable diseases in the research population Phase 3 Evaluating the effect of "Metaverse-Based Healthy Life Program for Youth" implementation on inculcating healthy lifestyle behaviors in youth

Eligibility criteria: Inclusion Criteria:

* Being a university student in the project partner countries and not older than 24,
* Having a score of 130 or lower on the HLBS II in the first stage of the research,
* Determining that BMI ≥ 25-34.99 kg/m2 in the first stage of the research and
* Using a smartwatch during the research,
* Accepting to participate in the research voluntarily

Exclusion Criteria:

* Having chronic diseases (asthma, diabetes, heart, kidney failure, hypertension, cancer, etc.)
* Those who have a drug that they use constantly
* Having a psychiatric diagnosis (depression, anxiety, bipolar disorder, schizophrenia, etc.)
* Having a disease that prevents the use of metaverse (vertigo, vision, hearing, etc.)

Primary outcomes:
measure: Healthy Lifestyle Behavior Scale II (HLBS II)
timeFrame: The HLBS II score will evaluate at baseline
measure: Healthy Lifestyle Behavior Scale II (HLBS II)
timeFrame: The HLBS II score will evaluate at third month
measure: Healthy Lifestyle Behavior Scale II (HLBS II)
timeFrame: The HLBS II score will evaluate at sixth month
measure: International Physical Activity Questionnaire-Short Form (IPAQ-SF)
timeFrame: The IPAQ-SF score will evaluate at baseline
measure: International Physical Activity Questionnaire-Short Form (IPAQ-SF)
timeFrame: The IPAQ-SF score will evaluate at third month
measure: International Physical Activity Questionnaire-Short Form (IPAQ-SF)
timeFrame: The IPAQ-SF score will evaluate at sixth month
measure: Positive and Negative Affect Schedule (PANAS-SF)
timeFrame: The PANAS-SF score will evaluate at baseline
measure: Positive and Negative Affect Schedule (PANAS-SF)
timeFrame: The PANAS-SF score will evaluate at third month
measure: Positive and Negative Affect Schedule (PANAS-SF)
timeFrame: The PANAS-SF score will evaluate at sixth month
Secondary outcomes:
Other outcomes:
Locations:
city: Antalya
country: Turkey
facility: Aysegul ISLER DALGIC
state: Konyaaltı
Study officials:
affiliation: Akdeniz University
name: Ayşegül İşler Dalgıç, Professor
role: STUDY_DIRECTOR
References: